Results 171 to 180 of about 154,358 (318)
Incidence of Cardiac Arrhythmias During Anesthesia [PDF]
William A. Sims+2 more
openalex +1 more source
Sleep-Disordered Breathing and Cardiac Arrhythmias. [PDF]
Menon T, Ogbu I, Kalra DK.
europepmc +1 more source
Inter‐atrial block as a predictor of adverse outcomes in patients with HFpEF
Abstract Aims Inter‐atrial block (IAB), a marker of electrical atrial dysfunction, is associated with an increased risk of atrial fibrillation (AF) and adverse events in various populations. The prognostic impact of IAB in heart failure (HF) with preserved ejection fraction (HFpEF) remains unknown.
Jerremy Weerts+11 more
wiley +1 more source
The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias [PDF]
A. M. Barrett, VALERIE A. CULLUM
openalex +1 more source
The Impact of Quality of Life on Cardiac Arrhythmias: A Clinical, Demographic, and AI-Assisted Statistical Investigation. [PDF]
Nechita LC+6 more
europepmc +1 more source
The state-of-the-art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview. [PDF]
MasoudKabir F+12 more
europepmc +1 more source
Atrial fibrillation (AF) was observed in almost half of patients with insertable cardiac monitor and symptomatic heart failure (HF). One‐fourth of the patients had new onset AF and a higher rate of HF events compared with patients without AF. AF incidence was similar in HF patients with preserved versus reduced left ventricular ejection fraction ...
Muhammad Shahzeb Khan+8 more
wiley +1 more source
The Interaction of Anesthetic Agents and Adrenergic Drugs to Produce Cardiac Arrhythmias [PDF]
Ronald L. Katz, Ralph Epstein
openalex +1 more source
Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias. [PDF]
Yavin H+4 more
europepmc +1 more source
Abstract Aims Large‐scale, real‐world data on early initiation of sacubitril/valsartan in patients newly diagnosed (de novo) with HF with reduced ejection fraction (HFrEF) are limited. We examined the effectiveness of sacubitril/valsartan versus angiotensin‐converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) on all‐cause and cause ...
Ankeet S. Bhatt+6 more
wiley +1 more source